Enokizumab
Modify Date: 2025-09-05 09:11:31
Enokizumab structure
|
Common Name | Enokizumab | ||
|---|---|---|---|---|
| CAS Number | 909875-08-7 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of EnokizumabEnokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways[1]. |
| Name | Enokizumab |
|---|
| Description | Enokizumab (MEDI-528) is a monoclonal antibody targeting to interleukin (IL)-9. IL-9 regulates the development of airway inflammation, mucus production, airway hyperresponsiveness, and airway fibrosis largely by increasing mast cell numbers and activity in the airways[1]. |
|---|---|
| Related Catalog | |
| Target |
IL-9[1] |
| No Any Chemical & Physical Properties |